MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01DAB215.244D3D30"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01DAB215.244D3D30
Content-Location: file:///C:/6808D4F8/UA177730101_03F8.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA177730101_03F8.files/filelist.xml">
<link rel=3DPreview href=3D"UA177730101_03F8.files/preview.wmf">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>yvr</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:LastPrinted>2019-07-16T08:24:00Z</o:LastPrinted>
  <o:Created>2024-05-29T19:11:00Z</o:Created>
  <o:LastSaved>2024-05-29T19:11:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>776</o:Words>
  <o:Characters>4426</o:Characters>
  <o:Company>Microsoft</o:Company>
  <o:Lines>36</o:Lines>
  <o:Paragraphs>10</o:Paragraphs>
  <o:CharactersWithSpaces>5192</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DthemeData href=3D"UA177730101_03F8.files/themedata.thmx">
<link rel=3DcolorSchemeMapping
href=3D"UA177730101_03F8.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 1 Знак";
	mso-style-next:Обычный;
	margin-top:24.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:14.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"Times New Roman";
	color:#365F91;
	mso-font-kerning:0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
h6
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 6 Знак";
	mso-style-next:Обычный;
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:11.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"Times New Roman";
	color:#243F60;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
span.1
	{mso-style-name:"Заголовок 1 Знак";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 1";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Cambria","serif";
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#365F91;
	mso-ansi-language:UK;
	font-weight:bold;}
span.6
	{mso-style-name:"Заголовок 6 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 6";
	font-family:"Cambria","serif";
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#243F60;
	mso-ansi-language:UK;
	font-style:italic;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:2.0cm 42.5pt 35.45pt 3.0cm;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU link=3Dblue vlink=3Dpurple style=3D'tab-interval:35.4pt'>

<div class=3DWordSection1>

<h6 align=3Dcenter style=3D'margin-top:0cm;text-align:center;line-height:no=
rmal'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
font-family:"Times New Roman","serif";color:windowtext;font-style:normal;
mso-bidi-font-style:italic'>ІНСТРУКЦІЯ<o:p></o:p></span></b></h6>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
для
медичного застосування лікарського засобу</span></b><b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-language:
UK'><o:p></o:p></span></b></p>

<h6 align=3Dcenter style=3D'text-align:center'><b style=3D'mso-bidi-font-we=
ight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;line-height:115%;font-family:"Times New=
 Roman","serif";
color:windowtext;font-style:normal;mso-bidi-font-style:italic'>ХЕДУССІН <o:=
p></o:p></span></b></h6>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;
line-height:115%;font-family:"Times New Roman","serif"'>(HEDUSSIN)<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-language:UK'>Склад:<span
style=3D'mso-spacerun:yes'>                                         </span>=
<span
style=3D'mso-spacerun:yes'>                                                =
  </span></span></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-family:Calibri;mso-fareast-language:UK'><span
style=3D'mso-spacerun:yes'>  </span></span></i><b><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-language:UK'><o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>діюча
речовина: </span></i><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-fon=
t-size:
11.0pt;font-family:"Times New Roman","serif"'>сухий екстракт листя плюща; <i
style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>100 мл сиропу містять 825 мг
сухого екстракту листя плюща (<i style=3D'mso-bidi-font-style:normal'>Hedera
helix</i> <i>L.</i>) (4–8:1); екстрагент: етанол 30 % (м/м);<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>допоміжні
речовини: </span></i><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-fon=
t-size:
11.0pt;font-family:"Times New Roman","serif"'>сорбіту розчин, що не кристал=
ізується,
калію сорбат, ксантанова камедь, кислота лимонна безводна, вода очищена;<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>2 мл сиропу містять до 0,938 г
цукрозамінної речовини сорбіту.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
<o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Лікарська
форма.</span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-si=
ze:11.0pt;
font-family:"Times New Roman","serif"'> Сироп.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
Основні
фізико-хімічні властивості: </span></i><span lang=3DUK style=3D'font-size:1=
2.0pt;
font-family:"Times New Roman","serif"'>коричнева ледь мутна рідина з солодк=
им
смаком. У процесі зберігання можливе утворення осаду.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Фармакотерапевтична
група. </span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-s=
ize:
11.0pt;font-family:"Times New Roman","serif"'>Засоби, що застосовуються при
кашлі та застудних захворюваннях. Відхаркувальні засоби. Код АТХ R05C A12. =
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif"'>Фармакологічні властивості.</span></=
i></b><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-family:"Times New Roman","serif"'> <o:p></o:p></spa=
n></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Фармакодинаміка.</span></i><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Препарат рослинного походженн=
я — містить
сухий екстракт листя плюща, біологічно активні речовини якого виявляють
протизапальну, спазмолітичну, секретолітичну дію, сприяють розширенню бронх=
ів
та полегшують відходження мокротиння.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Фармакокінетика.
<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Відсутні дані про фармакокіне=
тику
сухого екстракту листя плюща.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
Клінічні
характеристики.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Показання.=
 </span></i></b><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Гострі
запальні захворювання дихальних шляхів, що супроводжуються кашлем;
симптоматичне лікування хронічних запальних захворювань бронхів.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Протипоказ=
ання.</span></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'> </span></=
i><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Гіперчутливість
до діючої речовини, рослин родини аралієвих (<i style=3D'mso-bidi-font-styl=
e:
normal'>Araliaceae</i>) або до будь-якого іншого компонента лікарського зас=
обу.
Непереносимість фруктози.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Взаємодія з
іншими лікарськими засобами та інші види взаємодій.</span></i></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'> <o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>При одночасному застосуванні з
іншими лікарськими засобами небажаної дії препарату не спостерігалось. Тому
препарат можна застосовувати з іншими лікарськими засобами, наприклад з
антибіотиками.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:8.0pt;font-f=
amily:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Особливості
застосування.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Тривалий чи рецидивуючий каше=
ль у
дітей віком від 2 до 4 років вимагає медичного діагностування перед лікуван=
ням.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Якщо з’являється задишка, гар=
ячка
чи гнійне мокротиння, слід негайно проконсультуватися з лікарем.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Не рекомендується одночасне
застосування з протикашльовими препаратами, наприклад з кодеїном або
декстрометорфаном, без консультації лікаря.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>З обережністю застосовувати
пацієнтам з гастритом чи виразковою хворобою шлунка.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Якщо у пацієнта встановлена
непереносимість деяких цукрів, треба проконсультуватися з лікарем, перш ніж
приймати цей лікарський засіб.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Сорбіт, що входить до складу
лікарського засобу, може чинити незначний проносний ефект.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Застосування
у період вагітності або годування груддю.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Через відсутність достатніх д=
аних
не рекомендується застосовувати лікарський засіб у періоди вагітності або
годування груддю.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Здатність
впливати на швидкість реакції при керуванні автотранспортом або іншими
механізмами. </span></i><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-=
font-size:
11.0pt;font-family:"Times New Roman","serif"'>Дані відсутні.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Спосіб
застосування та дози.</span></i></b><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>
<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-language:UK'>Перед кожним застосуванн=
ям
необхідно ретельно збовтати сироп у флаконі. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-language:UK'>Застосовувати всередину:
дорослі та діти віком від 12 років — по 6 мл сиропу 2 рази на добу, діти ві=
ком
6–12 років — по 4 мл сиропу 2 рази на добу, 2–6 років — по 2 мл сиропу <span
style=3D'mso-spacerun:yes'>         </span>2 рази на добу.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-language:UK'>Тривалість курсу лікуван=
ня
визначає лікар індивідуально.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-language:UK'>Якщо симптоми захворюван=
ня
не зникли протягом 1 тижня застосовування лікарського засобу або з’явилися
будь-які небажані побічні реакції, не зазначені в цій інструкції, слід
припинити застосування препарату та звернутися до лікаря.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-language:UK'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
Діти</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
. Лікарський
засіб протипоказаний дітям віком до 2 років через ризик погіршення
респіраторних симптомів.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Передозува=
ння.</span></i></b><span
lang=3DUK style=3D'font-family:"Times New Roman","serif"'> <o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Перевищення рекомендованих доз
може викликати нудоту, блювання, діарею, збудження. Лікування симптоматичне=
. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Побічні
реакції. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Можуть спостерігатися алергіч=
ні
реакції, такі як <span style=3D'mso-spacerun:yes'> </span>задишка, набряк К=
вінке,
висипання на шкірі, кропив’янка, свербіж. Частота невідома.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>У пацієнтів із підвищеною
чутливістю можуть спостерігатися шлунково-кишкові розлади, зокрема нудота,
блювання, діарея, біль у животі, — через вміст сорбіту. <o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>В разі виникнення будь-яких п=
обічних
реакцій, що не зазначені вище, необхідно проконсультуватися з лікарем.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:6.0pt;mso-bi=
di-font-size:
5.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Повідомлення про побічні реак=
ції<b
style=3D'mso-bidi-font-weight:normal'> </b>після реєстрації лікарського зас=
обу
має важливе значення. Це дає змогу проводити моніторинг співвідношення
користь/ризик при застосуванні цього лікарського засобу. Медичним та
фармацевтичним працівникам, а також пацієнтам або їхнім законним представни=
кам
слід повідомляти про усі випадки підозрюваних побічних реакцій та відсутнос=
ті
ефективності лікарського засобу через автоматизовану інформаційну систему з
фармаконагляду за посиланням: </span><span lang=3DUK><a
href=3D"https://aisf.dec.gov.ua"><span style=3D'font-size:12.0pt;mso-bidi-f=
ont-size:
11.0pt;font-family:"Times New Roman","serif";color:windowtext'>https://aisf=
.dec.gov.ua</span></a></span><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-bidi-font-size:11.0pt;font-family:"Times New Roman","serif"'>Термін
придатності.</span></i></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bi=
di-font-size:
11.0pt;font-family:"Times New Roman","serif"'> 3 роки. <o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Після першого відкривання фла=
кона
препарат можна застосовувати протягом 3 місяців.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Не застосовувати після закінч=
ення
терміну придатності, зазначеного на упаковці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Умови
зберігання. </span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-f=
ont-size:
11.0pt;font-family:"Times New Roman","serif"'>Лікарський засіб не потребує
особливих умов зберігання.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Зберігати у недоступному для
дітей місці. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'>Після відкривання флакона
зберігати при температурі не вище 25 &ordm;С.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Упаковка.
</span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.=
0pt;
font-family:"Times New Roman","serif"'>По 100 мл у флаконі, по 1 флакону з
мірною ложкою в картонній коробці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"=
Times New Roman","serif"'>Категорія
відпуску. </span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-fon=
t-size:
11.0pt;font-family:"Times New Roman","serif"'>Без рецепта.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;mso-b=
idi-font-size:
11.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;text-autospace:none'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-language:UK'>Виробник.</span></b><span lang=3DUK style=3D'font-=
size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-language:UK'> Фіто=
фарм
Кленка С.А.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;text-autospace:none'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-language:UK'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;text-autospace:none'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-language:UK'>Місцезнаходження виробника та адреса місця провадж=
ення
його діяльності.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Кленка 1, 63-040, Нове М’ясто над Вартою, Польща=
.<o:p></o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01DAB215.244D3D30
Content-Location: file:///C:/6808D4F8/UA177730101_03F8.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01DAB215.244D3D30
Content-Location: file:///C:/6808D4F8/UA177730101_03F8.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01DAB215.244D3D30
Content-Location: file:///C:/6808D4F8/UA177730101_03F8.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01DAB215.244D3D30
Content-Location: file:///C:/6808D4F8/UA177730101_03F8.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA177730101_03F8.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01DAB215.244D3D30--
